Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

A comprehensive review has explored the diverse roles of extracellular vesicles (EVs) in the oral and maxillofacial region, ...

Reconstructive surgery, essential for restoring function and appearance after trauma or disease, has undergone significant transformation due to ...